Globulin, Immune

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), American National Red Cross

Conditions

Cytomegalovirus RetinitisHIV InfectionsPregnancy

Phase 3

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

CompletedNCT00000751

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)HIV Infections, Pregnancy

End: 2007-08-31Target: 1600Updated: 2008-09-30

A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine

CompletedNCT00000720

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 1993-04-30Target: 250Updated: 2021-11-03

Unknown Phase

A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

CompletedNCT00001999

American National Red CrossCytomegalovirus Retinitis, HIV Infections

Updated: 2005-06-24